Bank of America
GSK icon

Bank of America’s GSK GSK Stock Holding History

Bank of America’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$122M Sell
2,206,152
-1,546,950
-41% -$83.8M 0.01% 984
2025
Q4 		$184M Sell
3,753,102
-772,943
-17% -$36.1M 0.01% 776
2025
Q3 		$195M Sell
4,526,045
-542,642
-11% -$21.2M 0.01% 826
2025
Q2 		$195M Buy
5,068,687
+2,531,972
+100% +$96.7M 0.01% 797
2025
Q1 		$98.3M Buy
2,536,715
+554,452
+28% +$20.3M 0.01% 1080
2024
Q4 		$67M Sell
1,982,263
-278,431
-12% -$10M 0.01% 1281
2024
Q3 		$92.4M Buy
2,260,694
+17,546
+0.8% +$718K 0.01% 1117
2024
Q2 		$86.4M Buy
2,243,148
+70,107
+3% +$2.95M 0.01% 1096
2024
Q1 		$93.2M Buy
2,173,041
+203,155
+10% +$8.38M 0.01% 1068
2023
Q4 		$73M Sell
1,969,886
-96,738
-5% -$3.47M 0.01% 1122
2023
Q3 		$74.9M Sell
2,066,624
-24,092
-1% -$855K 0.01% 1037
2023
Q2 		$74.5M Sell
2,090,716
-1,790
-0.1% -$64.2K 0.01% 1052
2023
Q1 		$74.5M Sell
2,092,506
-254,575
-11% -$8.91M 0.01% 1104
2022
Q4 		$82.5M Sell
2,347,081
-197,603
-8% -$6.58M 0.01% 994
2022
Q3 		$74.9M Sell
2,544,684
-18,038
-0.7% -$684K 0.01% 993
2022
Q2 		$139M Buy
2,562,722
+123,367
+5% +$6.81M 0.02% 745
2022
Q1 		$133M Sell
2,439,355
-54,239
-2% -$2.95M 0.01% 817
2021
Q4 		$137M Sell
2,493,594
-397,584
-14% -$20.7M 0.01% 842
2021
Q3 		$138M Buy
2,891,178
+314,394
+12% +$15.8M 0.01% 803
2021
Q2 		$128M Buy
2,576,784
+70,253
+3% +$3.38M 0.01% 823
2021
Q1 		$112M Sell
2,506,531
-216,271
-8% -$9.82M 0.01% 828
2020
Q4 		$125M Sell
2,722,802
-1,812,956
-40% -$83.3M 0.02% 688
2020
Q3 		$213M Sell
4,535,758
-489,528
-10% -$24.5M 0.03% 470
2020
Q2 		$256M Sell
5,025,286
-452,044
-8% -$23.2M 0.04% 390
2020
Q1 		$259M Sell
5,477,330
-482,775
-8% -$25.8M 0.05% 348
2019
Q4 		$350M Buy
5,960,105
+124,791
+2% +$6.94M 0.05% 343
2019
Q3 		$311M Sell
5,835,314
-402,895
-6% -$20.7M 0.05% 367
2019
Q2 		$312M Sell
6,238,209
-235,417
-4% -$11.8M 0.05% 361
2019
Q1 		$338M Buy
6,473,626
+369,031
+6% +$18.4M 0.05% 328
2018
Q4 		$292M Sell
6,104,595
-508,522
-8% -$25M 0.05% 336
2018
Q3 		$332M Buy
6,613,117
+452,974
+7% +$23M 0.05% 339
2018
Q2 		$310M Sell
6,160,143
-26,220
-0.4% -$1.32M 0.05% 333
2018
Q1 		$302M Buy
6,186,363
+783,111
+14% +$36.5M 0.05% 340
2017
Q4 		$240M Sell
5,403,252
-2,700,459
-33% -$125M 0.04% 397
2017
Q3 		$411M Buy
8,103,711
+1,999,710
+33% +$101M 0.07% 293
2017
Q2 		$329M Buy
6,104,001
+624,295
+11% +$33.3M 0.07% 295
2017
Q1 		$289M Buy
5,479,706
+747,943
+16% +$37.9M 0.06% 312
2016
Q4 		$228M Sell
4,731,763
-606,132
-11% -$29.9M 0.05% 366
2016
Q3 		$288M Buy
5,337,895
+433,104
+9% +$23.7M 0.06% 303
2016
Q2 		$266M Buy
4,904,791
+812,781
+20% +$42.8M 0.06% 311
2016
Q1 		$207M Buy
4,092,010
+573,050
+16% +$28.5M 0.05% 367
2015
Q4 		$177M Sell
3,518,960
-35,268
-1% -$1.8M 0.04% 438
2015
Q3 		$171M Buy
3,554,228
+1,619,041
+84% +$84.3M 0.04% 449
2015
Q2 		$101M Sell
1,935,187
-319,979
-14% -$18M 0.03% 535
2015
Q1 		$130M Sell
2,255,166
-1,079,052
-32% -$61.9M 0.04% 415
2014
Q4 		$178M Sell
3,334,218
-5,401,868
-62% -$302M 0.06% 349
2014
Q3 		$502M Buy
8,736,086
+126,365
+1% +$7.75M 0.16% 132
2014
Q2 		$576M Buy
8,609,721
+1,243,646
+17% +$84.2M 0.18% 122
2014
Q1 		$492M Buy
7,366,075
+604,973
+9% +$40.9M 0.18% 121
2013
Q4 		$451M Buy
6,761,102
+4,110,959
+155% +$267M 0.16% 133
2013
Q3 		$166M Sell
2,650,143
-63,681
-2% -$4.1M 0.07% 300
2013
Q2 		$170M Buy
+2,713,824
New +$172M 0.07% 267

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of America's GSK Position: Q1 2026 in Review

Bank of America reduced its GSK (GSK) stake by 41% in Q1 2026, selling an estimated $83.8M and leaving 2,206,152 shares worth $122M. The position accounts for 0.01% of the portfolio, ranked #984.

Bank of America first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $576M in Q2 2014. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Bank of America held 2,206,152 shares of GSK worth $122M as of Q1 2026.
  • Bank of America sold 1,546,950 GSK shares in Q1 2026, an estimated $83.8M.
  • GSK made up 0.01% of Bank of America's portfolio in Q1 2026, its #984 holding.
  • Bank of America first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's GSK position peaked at $576M in Q2 2014.
  • 1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.